Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).
暂无分享，去创建一个
T. Alonzo | M. Mooney | D. Hawkins | J. Reid | A. Sabnis | S. Roy-Chowdhuri | K. Janeway | N. Takebe | N. Seibel | A. Jaju | S. Berg | J. V. Tricoli | E. Fox | D. Patton | Lauren Saguilig | J. Piao | D. W. Parsons | P. Williams | K. Vo | Brent D. Coffey